Divi's Laboratories Limited (DIVISLAB.BO)
INR 5389.5
(2.42%)
INR 5389.5
(2.42%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 33.08 Billion INR | -11.41% |
| 2022 | 20.62 Billion INR | -42.1% |
| 2021 | 35.61 Billion INR | 39.08% |
| 2020 | 25.6 Billion INR | 59.21% |
| 2019 | 16.08 Billion INR | -2.48% |
| 2018 | 16.49 Billion INR | 52.96% |
| 2017 | 10.78 Billion INR | -21.88% |
| 2016 | 13.8 Billion INR | 5.23% |
| 2015 | 13.11 Billion INR | 21.47% |
| 2014 | 10.79 Billion INR | 8.26% |
| 2013 | 9.97 Billion INR | 27.43% |
| 2012 | 7.82 Billion INR | 14.43% |
| 2011 | 6.84 Billion INR | 44.67% |
| 2010 | 4.72 Billion INR | 60.44% |
| 2009 | 2.94 Billion INR | -35.3% |
| 2008 | 4.55 Billion INR | -95.29% |
| 2007 | 96.72 Billion INR | 4312.1% |
| 2006 | 2.19 Billion INR | 107.45% |
| 2005 | 1.05 Billion INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 5.26 Billion INR | 52.99% |
| 2023 Q3 | 3.94 Billion INR | 2.6% |
| 2023 FY | 18.27 Billion INR | -11.41% |
| 2023 Q2 | 3.84 Billion INR | -6.57% |
| 2023 Q1 | 4.11 Billion INR | 1.54% |
| 2023 Q4 | 6.36 Billion INR | 61.42% |
| 2022 Q3 | 3.21 Billion INR | -39.94% |
| 2022 FY | 20.62 Billion INR | -42.1% |
| 2022 Q1 | 7.63 Billion INR | -25.44% |
| 2022 Q2 | 5.35 Billion INR | -29.85% |
| 2022 Q4 | 4.04 Billion INR | 25.9% |
| 2021 Q2 | 7.47 Billion INR | -3.97% |
| 2021 Q3 | 10.2 Billion INR | 36.44% |
| 2021 Q4 | 10.23 Billion INR | 0.3% |
| 2021 FY | 35.61 Billion INR | 39.08% |
| 2021 Q1 | 7.78 Billion INR | 20.52% |
| 2020 FY | 25.6 Billion INR | 59.21% |
| 2020 Q4 | 6.46 Billion INR | 0.6% |
| 2020 Q3 | 6.42 Billion INR | -7.4% |
| 2020 Q2 | 6.93 Billion INR | 4.91% |
| 2020 Q1 | 6.61 Billion INR | 59.22% |
| 2019 FY | 16.08 Billion INR | -2.48% |
| 2019 Q3 | 4.88 Billion INR | -0.57% |
| 2019 Q2 | 4.91 Billion INR | 31.59% |
| 2019 Q4 | 4.15 Billion INR | -15.06% |
| 2019 Q1 | 3.73 Billion INR | -3.58% |
| 2018 Q1 | 3.59 Billion INR | 0.0% |
| 2018 FY | 16.49 Billion INR | 52.96% |
| 2018 Q4 | 3.87 Billion INR | -26.16% |
| 2018 Q3 | 5.24 Billion INR | -6.2% |
| 2018 Q2 | 5.59 Billion INR | 55.68% |
| 2017 FY | 10.78 Billion INR | -21.88% |
| 2016 FY | 13.8 Billion INR | 5.23% |
| 2015 FY | 13.11 Billion INR | 21.47% |
| 2014 Q4 | 2.93 Billion INR | 0.0% |
| 2014 FY | 10.79 Billion INR | 8.26% |
| 2013 Q4 | 2.54 Billion INR | 0.0% |
| 2013 FY | 9.97 Billion INR | 27.43% |
| 2012 Q4 | 2.37 Billion INR | 0.0% |
| 2012 FY | 7.82 Billion INR | 14.43% |
| 2011 FY | 6.84 Billion INR | 44.67% |
| 2010 FY | 4.72 Billion INR | 60.44% |
| 2009 FY | 2.94 Billion INR | -35.3% |
| 2008 FY | 4.55 Billion INR | -95.29% |
| 2007 FY | 96.72 Billion INR | 4312.1% |
| 2006 FY | 2.19 Billion INR | 107.45% |
| 2005 FY | 1.05 Billion INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | -474.495% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 21.617% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | -268.407% |
| Granules India Limited | 6.81 Billion INR | -385.278% |
| Indoco Remedies Limited | 1.29 Billion INR | -2459.284% |
| Achyut Healthcare Limited | 4.43 Million INR | -745280.802% |
| Ajanta Pharma Limited | 19.67 Billion INR | -68.112% |
| Alkem Laboratories Limited | 19.46 Billion INR | -69.973% |
| Alpa Laboratories Limited | 184.49 Million INR | -17829.831% |
| Brooks Laboratories Limited | 14.44 Million INR | -228985.873% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | -1826.055% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -2587.244% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 51.158% |
| Eris Lifesciences Limited | 5.18 Billion INR | -538.398% |
| FDC Limited | 2.98 Billion INR | -1007.759% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | -408.737% |
| Gufic Biosciences Limited | 1.32 Billion INR | -2387.386% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | -648.323% |
| Ipca Laboratories Limited | 7.98 Billion INR | -314.505% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -6410.145% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 21869.316% |
| Lasa Supergenerics Limited | -458 Million INR | 7322.629% |
| Laurus Labs Limited | 3.94 Billion INR | -737.765% |
| Lupin Limited | 28.04 Billion INR | -17.955% |
| Mankind Pharma Limited | 21.51 Billion INR | -53.731% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -32881.057% |
| Megasoft Limited | -121.1 Million INR | 27415.365% |
| NATCO Pharma Limited | 25.96 Billion INR | -27.417% |
| Piramal Pharma Limited | 4.55 Billion INR | -625.932% |
| RPG Life Sciences Limited | 2.29 Billion INR | -1343.092% |
| Sigachi Industries Limited | 1.47 Billion INR | -2144.392% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 68.285% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | -617.938% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -13171.762% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -5706.402% |
| Windlas Biotech Limited | 1.29 Billion INR | -2446.79% |
| ZIM Laboratories Limited | 253.82 Million INR | -12932.396% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 23.261% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 903.88% |
| Hester Biosciences Limited | 364.81 Million INR | -8967.734% |
| Procter & Gamble Health Limited | 2.78 Billion INR | -1087.365% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -7129.906% |
| Bal Pharma Limited | 233.9 Million INR | -14042.252% |
| Strides Pharma Science Limited | 5.22 Billion INR | -533.012% |
| Venus Remedies Limited | 534.65 Million INR | -6087.214% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | -957.506% |
| Nectar Lifesciences Limited | 923.8 Million INR | -3480.838% |
| Shilpa Medicare Limited | 1.36 Billion INR | -2321.187% |
| Aarti Drugs Limited | 7.14 Billion INR | -362.74% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | -1971.643% |
| Suven Life Sciences Limited | -1.22 Billion INR | 2798.597% |
| Ind-Swift Limited | 1.22 Billion INR | -2598.285% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | -131.607% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 958.574% |
| Themis Medicare Limited | 392.58 Million INR | -8326.115% |
| Hikal Limited | 32.11 Million INR | -102920.866% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | -30.569% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -5180.128% |
| Wockhardt Limited | -670 Million INR | 5037.313% |
| Jubilant Pharmova Limited | 5.18 Billion INR | -537.502% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -364671.136% |
| Neuland Laboratories Limited | 5.31 Billion INR | -522.028% |
| Morepen Laboratories Limited | 4.17 Billion INR | -692.557% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -15800.024% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -120374.907% |